At a glance
ClinicalIndex Comparison RecordN/ACompleted· 227 enrolled
Drug / intervention
Ultrasound and Doppler ultrasoundother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Clinical Utility of Uterine, Fetal Cerebral Doppler and Oligohydramnios to Predict Abnormal Heart Rate Tracings in Pregnancies at or Beyond 41 Weeks
In Brief
An observational study evaluating Ultrasound and Doppler ultrasound for Abnormality in Fetal Heart Rate or Rhythm and 2 related conditions. Completed, enrolled 227 participants across 1 site.
Detailed Summary
Objective: To estimate the value of uterine, fetal cerebral Doppler and oligohydramnios to predict abnormal fetal heart rate tracings in pregnancies at or beyond 41 weeks
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesMexico
Collaborators--
Timeline
N/ACompletedFinished
20162017201820192020202120222023202420252026
Enrollment StartJan 2016
First PostedOct 2018
Primary CompletionFeb 2019
Study CompletionOct 2019
TodayJul 2026
First PostedOct 11, 2018
Enrollment StartJan 1, 2016
Primary CompletionFeb 1, 2019
Study CompletionOct 1, 2019
TodayJul 2, 2026
Enrollment to primary: 3.1 yearsPosted 7.7 years ago
Interventions
Ultrasound and Doppler ultrasoundother
Assessment of fetal cerebral and maternal uterine pulsatility index using Doppler ultrasound. Measurement of amniotic fluid index according to four-quadrant technique.